Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

C3_RECTUM_ADENO_MUCINO_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C20.92& Cause of death: ICD-10 — C20.92& Cancer registry: Topography ICD-O-3 — C19\|C20 Cancer registry: Morphology ICD-O-3 — 8140\|8480 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	3886
4. Check minimum number of events None	3886
5. Include endpoints None	3886
6. Filter based on genotype QC (FinnGen only)	3886

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12
Name in latin: Carcinoma in situ cavitatis oris, oesophagi sive ventriculi

NAME	C3_RECTUM_ADENO_MUCINO_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C2092
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2092
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C19\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140\|8480
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3886	1452	2434
Unadjusted period prevalence (%)	0.86	0.49	1.07
Median age at first event (years)	67.77	66.20	68.70

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3442: Matched controls
34418

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

16384.0

323.0

1600

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

5.5

323.0

1643

4900

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

4685.7

323.0

424

JG1BG

NOMESCO Finland

MRI of rectum

657.5

323.0

555

Z93.3

ICD-10 Finland

Colostomy status

205.2

323.0

447

JN4AD

NOMESCO Finland

Body CT examination

17.7

323.0

739

522

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

323.0

512

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

323.0

360

JFF23

NOMESCO Finland

Transversostomy

351.4

323.0

723

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

619.5

323.0

387

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

323.0

491

B01AB05

ATC

enoxaparin; parenteral

5.6

323.0

1892

6153

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

448

JG1CG

NOMESCO Finland

Extensive MRI of rectum

1692.3

323.0

438

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

541

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

317.6

323.0

646

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

323.0

408

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

2090.7

323.0

356

D75

ICPC

Malignant neoplasm colon/rectum

708.8

323.0

380

UJF32

NOMESCO Finland

Coloscopy

12.1

323.0

2398

5502

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

323.0

808

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

279.5

323.0

418

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

377

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

311.2

323.0

435

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

323.0

423

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

38.4

323.0

589

184

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

24.5

323.0

1680

1287

JN4BD

NOMESCO Finland

Extensive body CT

23.6

323.0

1254

816

H02AB02

ATC

dexamethasone; systemic

87.0

323.0

963

153

WX302

NOMESCO Finland

Thoracal epidural anesthesy

59.9

323.0

1113

272

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1847.6

323.0

602

A03FA01

ATC

metoclopramide; systemic, rectal

18.4

323.0

1759

1850

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

740

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

21.9

323.0

548

295

WX408

NOMESCO Finland

General anesthesy, balanced

5.0

323.0

1536

4761

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

19.1

323.0

923

648

WZC30

NOMESCO Finland

Teaching

7.8

323.0

948

1596

A04AA02

ATC

granisetron; systemic, transdermal

1618.2

323.0

854

L01BC06

ATC

capecitabine; oral

+∞

323.0

1552

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

597

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

1888

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

80.4

323.0

418

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

2904

TJF80

NOMESCO Finland

Ostomy education

168.0

323.0

453

XX3DW

NOMESCO Finland

Time consuming IT work

14.8

323.0

784

673

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2303.0

323.0

383

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2882

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

4801.6

323.0

433

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

801.0

302.8

294

UJG02

NOMESCO Finland

Proctoscopy

21.2

295.5

449

242

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

294.0

278

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

175.3

292.3

304

C61

ICD-10 Finland

Malignant neoplasm of prostate

268.6

291.7

295

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2688.8

272.3

260

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2654.1

269.1

257

ZX090

NOMESCO Finland

Other technic of radiotherapy

531.4

252.1

248

WX600

NOMESCO Finland

Single shot through catheter

75.9

246.5

280

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1270.4

245.7

237

WF002

NOMESCO Finland

Radical radiotherapy

146.6

244.2

258

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2334.2

239.2

229

JN4CD

NOMESCO Finland

Very extensive body CT

18.7

235.2

372

221

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

128.2

233.7

250

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

796.2

230.0

224

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

97.5

229.8

253

A04AA01

ATC

ondansetron; systemic, rectal

16.7

228.8

378

252

WF049

NOMESCO Finland

Radiotherapy of metastasis

1178.6

228.6

221

Z51.5

ICD-10 Finland

Palliative care

13.9

226.3

404

325

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

225.5

214

TPH07

NOMESCO Finland

Cathetrisation of artery

5.2

218.0

762

1769

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

2042.1

211.5

203

ZXC96

NOMESCO Finland

Robot assisted procedure

54.0

209.4

251

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

716.6

207.7

203

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

533.6

205.0

202

WX402

NOMESCO Finland

General anaesthesia

4.5

197.0

797

2137

B01AB10

ATC

tinzaparin; parenteral

8.3

195.6

465

639

N02AA05

ATC

oxycodone; systemic

4.4

192.1

814

2278

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

2020.6

188.1

181

JFF10

NOMESCO Finland

Loop enterostomy

124.1

185.3

199

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

185.0

176

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

186.4

170.4

177

WF003

NOMESCO Finland

Adjuvant radiotherapy

438.4

169.2

168

SPAT1125

SPAT

Stoma care and guidance

18.3

167.4

266

157

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.6

167.0

358

409

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

1749.1

167.0

161

116

Kela drug reimbursment

Prostate cancer

+∞

154.3

147

WF004

NOMESCO Finland

Palliative radiotherapy

1565.8

152.2

147

A04AA55

ATC

palonosetron, combinations; systemic

+∞

145.8

139

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

6.8

140.3

377

610

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.2

136.6

585

1604

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

103.0

135.2

148

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

132.1

126

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.9

131.8

397

744

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.1

129.9

256

247

A04AD12

ATC

aprepitant; systemic

1295.1

129.0

125

Z93

ICD-10 Finland

Artificial opening status

117.9

126.0

136

ZX120

NOMESCO Finland

Intravenous

4.6

125.0

473

1143

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

57.3

120.7

143

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

118.4

113

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

301.8

114.8

116

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.5

113.9

231

235

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

113.1

108

JN3AD

NOMESCO Finland

Abdominal CT examination

4.5

112.5

439

1088

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.0

110.4

387

858

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.7

107.5

534

1642

115

Kela drug reimbursment

Breast cancer

+∞

106.8

102

Z51.0

ICD-10 Finland

Radiotherapy session

1059.8

105.9

103

SPAT1262

SPAT

Handing over of treatment supplies

2.6

104.7

939

4314

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

11.3

104.1

202

188

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

101.0

361

814

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

99.4

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

99.4

D18

ICPC

Change in faeces/bowel movements

9.5

98.6

211

236

JF2AB

NOMESCO Finland

Colongraphy with X-ray

100.3

97.5

107

369

Kela drug reimbursment

Regorafenib

+∞

97.3

L01BC59

ATC

trifluridine, combinations; systemic

+∞

97.3

TQW40

NOMESCO Finland

Remowal of suture of skin

4.3

96.7

387

977

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

953.8

95.4

A79

ICPC

Malignancy NOS

201.6

94.8

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

94.2

Z43.3

ICD-10 Finland

Attention to colostomy

199.4

93.8

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

21.4

93.7

140

N02BE01

ATC

paracetamol; systemic, rectal

2.6

93.2

2961

24251

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

93.1

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

50.2

92.5

112

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

92.1

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

92.1

PJA12

NOMESCO Finland

Sentinel node biopsy

464.7

91.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.1

91.4

311

663

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

91.0

WW500

NOMESCO Finland

Blood transfusion

7.9

90.6

216

289

L03AA13

ATC

pegfilgrastim; parenteral

890.6

89.1

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

233.5

88.9

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

74.1

88.8

101

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

88.5

870

4143

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.6

87.9

271

515

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

14.9

87.4

149

104

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

86.8

JAH00

NOMESCO Finland

Laparotomy

7.6

85.2

209

292

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

82.6

176

Kela drug reimbursment

Regorafenib

+∞

82.6

L02AE02

ATC

leuprorelin; implant, parenteral

48.9

82.3

100

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

6.2

79.6

225

383

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

785.6

78.7

1XC07

NOMESCO Finland

+∞

78.4

R4110

NOMESCO Finland

Physiotherapy

2.2

76.7

1007

5460

D99

ICPC

Disease digestive system other

15.0

76.5

130

JJB10

NOMESCO Finland

Atypcal resection of liver

385.6

76.1

L03AA02

ATC

filgrastim; parenteral

68.5

75.7

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

11.8

74.6

141

124

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

69.8

71.6

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

71.1

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

359.4

70.9

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

70.0

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

34.6

69.8

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

69.0

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

67.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.8

67.6

201

364

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

670.8

67.2

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

+∞

66.9

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

338.4

66.7

JFB00

NOMESCO Finland

Partial resection of small intestine

9.5

66.0

139

151

Z43.2

ICD-10 Finland

Attention to ileostomy

69.5

65.5

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

53.1

65.3

K56.7

ICD-10 Finland

Ileus, unspecified

8.6

63.5

142

171

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

42.5

63.4

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

22.2

63.3

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

61.2

61.7

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

61.6

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

15.4

61.0

102

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

608.4

60.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

8.3

60.4

138

172

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.1

59.6

169

288

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

21.0

58.9

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

58.5

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

74.8

58.2

Y77

ICPC

Malignant neoplasm prostate

106.9

58.0

E0000UV

ATC

1.9

56.8

1267

8238

L01XE21

ATC

[U] regorafenib; oral

+∞

56.4

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

556.6

55.7

Z93.2

ICD-10 Finland

Ileostomy status

41.4

55.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

54.8

458

1943

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

30.6

53.8

R4190

NOMESCO Finland

Nutritional therapy

7.1

52.8

133

193

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

52.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

52.2

B01AB04

ATC

dalteparin; parenteral

3.6

52.0

249

726

L02BB03

ATC

bicalutamide; oral

515.3

51.6

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

515.3

51.6

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

264.4

51.2

XX1AD

NOMESCO Finland

Other CT-examination

179.3

51.0

JFF24

NOMESCO Finland

Laparoscopic transversostomy

504.9

50.5

L02BG04

ATC

letrozole; oral

40.1

50.1

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

49.1

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.4

48.9

133

215

WX704

NOMESCO Finland

Intubation

3.1

48.2

288

990

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

248.3

48.1

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

48.0

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

38.1

47.3

ZZR00

NOMESCO Finland

Flap of skin

11.8

47.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

47.1

597

3092

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.1

46.5

153

312

HAC20

NOMESCO Finland

Total mastectomy

463.7

46.4

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

47.4

46.1

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

45.9

N03AX16

ATC

pregabalin; oral

1.9

45.8

804

4730

S18

ICPC

Laceration/cut

1.7

44.2

1398

9909

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.3

44.0

120

195

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

222.7

43.0

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

18.7

42.7

6434

FHL

Anterior resection

93.2

41.8

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

19.1

41.8

JAH01

NOMESCO Finland

Laparoscopy

4.5

41.8

156

363

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

41.7

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

41.6

191

537

6435

FHL

Abdominoperineal resection and colostomy

412.2

41.2

JFF26

NOMESCO Finland

Sigmoidostomy

37.7

41.0

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.0

40.8

173

454

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.5

40.3

123

230

V03AF03

ATC

calcium folinate; systemic

207.3

39.9

JJB30

NOMESCO Finland

Excision of two segments of liver

+∞

39.6

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

39.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

39.6

1478

10863

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

25.4

39.3

L01BC53

ATC

tegafur, combinations; systemic

+∞

38.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

38.6

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

381.4

38.1

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

37.6

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.5

37.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

37.2

842

5336

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.2

37.1

118

232

KCC10

NOMESCO Finland

Cystoprostatectomy

371.1

37.1

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

83.0

36.8

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

36.8

341

1513

K92.1

ICD-10 Finland

Melaena

2.8

36.8

251

939

Z31.5

ICD-10 Finland

Genetic counselling

4.9

36.7

123

256

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.0

36.6

153

397

D70.82

ICD-10 Finland

Drug-induced neutropenia

21.1

36.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.2

36.5

202

657

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.8

36.3

246

914

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.1

36.3

132

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

69.0

36.0

NK6AN

NOMESCO Finland

Total body bone isotope imaging

27.6

35.9

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.6

35.8

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

98.6

35.8

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

35.5

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

35.5

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

19.9

33.9

R50.9

ICD-10 Finland

Fever, unspecified

2.1

33.9

436

2246

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

176.6

33.8

D77

ICPC

Malignant digestive neopl other/NOS

176.6

33.8

J01MA12

ATC

levofloxacin; systemic

1.8

33.6

626

3708

SPAT1153

SPAT

Removal of sutures

1.6

33.5

1043

7216

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.7

32.7

148

411

JFB30

NOMESCO Finland

Right hemicolectomy

10.9

32.6

HAB40

NOMESCO Finland

Wedge excision of mammary gland

19.9

32.6

A06AH03

ATC

naloxegol; oral

14.3

32.4

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

32.3

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

32.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

32.3

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

32.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

32.3

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.0

32.1

133

342

L02BA01

ATC

tamoxifen; oral

34.5

31.8

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

166.5

31.7

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

8.3

31.7

D16

ICPC

Rectal bleeding

4.5

31.4

114

259

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

31.3

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

39.4

31.2

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

60.6

31.1

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

315.5

30.9

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.6

30.8

126

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

13.8

30.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

111.0

30.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

111.0

30.7

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

26.5

30.6

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

20.7

30.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

8.5

30.4

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

15.3

30.3

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

13.9

30.3

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.2

30.2

189

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

30.2

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

30.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

30.2

WX110

NOMESCO Finland

Local anesthesy

1.5

29.9

1933

15782

C50.99

ICD-10 Finland

Breast, unspecified

304.9

29.8

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

156.3

29.7

LEC00

NOMESCO Finland

Partial excision of vagina

156.3

29.7

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

29.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

29.2

C209

ICD-10 Finland

+∞

29.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

29.1

583

3517

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

28.9

277

1248

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

28.8

269

1196

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

294.2

28.8

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

10.9

28.7

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.6

28.4

114

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

28.1

210

828

TJG20

NOMESCO Finland

Transanal irrigation

33.0

27.8

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

100.8

27.7

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

100.8

27.7

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

100.8

27.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

35.3

27.4

TPX15

NOMESCO Finland

Removal of vascular injection port

23.2

27.4

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.6

27.3

128

367

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

27.1

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

27.1

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

27.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

27.1

JEA00

NOMESCO Finland

Appendectomy

2.7

27.0

193

741

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

17.7

27.0

P01AB01

ATC

metronidazole; oral, rectal

1.5

27.0

1103

8064

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

26.9

172

617

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.7

26.9

206

A02BC02

ATC

pantoprazole; systemic

1.5

26.8

2012

16770

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

26.4

176

645

G04BE03

ATC

sildenafil; oral

11.0

26.3

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

26.1

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

26.1

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

60.5

26.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

25.4

264

1236

JHA00

NOMESCO Finland

Anal or perianal incision

6.4

25.3

106

A06AD11

ATC

lactulose; oral

1.8

25.3

525

3193

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

9.7

25.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.4

25.2

142

8480/3-C19.9

ICD-O-3

Mucinous adenocarcinoma of rectosigmoid junction

+∞

25.0

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

25.0

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

8.8

24.7

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

17.4

24.4

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

56.4

24.0

HA1AA

NOMESCO Finland

X-ray mammography

3.8

24.0

104

280

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

24.0

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

24.0

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

24.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

241.5

23.7

JFF30

NOMESCO Finland

Other colostomy

47.0

23.3

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.7

23.1

170

ZX121

NOMESCO Finland

Central venous catheter

22.2

23.0

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

L02BX02

ATC

degarelix; parenteral

+∞

22.9

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

22.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

22.9

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

22.9

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.7

22.7

UKC02

NOMESCO Finland

Cystoscopy

1.7

22.7

548

3478

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.2

22.5

207

D28

ICPC

Limited function/disability (D)

14.9

22.4

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

22.3

237

1118

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.3

22.0

115

361

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

21.9

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.5

21.8

120

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

21.8

375

2138

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

38.9

21.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

21.7

256

1266

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

221.2

21.6

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

221.2

21.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

221.2

21.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

115.7

21.6

WX882

NOMESCO Finland

High dependency care

3.3

21.5

111

345

ZX050

NOMESCO Finland

Stereotactic radiotherapy

26.6

21.3

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

20.8

21.2

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

21.2

180

762

UJF34

NOMESCO Finland

Left colonoscopy

8.1

20.9

J01MA02

ATC

ciprofloxacin; systemic

1.4

20.9

1219

9485

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

20.8

D29

ICPC

Digestive symptom/complaint other

4.1

20.8

204

L03AA14

ATC

lipegfilgrastim; parenteral

211.1

20.6

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

110.6

20.6

NET99

NOMESCO Finland

Other operation on pelvis

110.6

20.6

JFB20

NOMESCO Finland

Ileocaecal resection

12.0

20.5

R33

ICD-10 Finland

Retention of urine

1.9

20.3

320

1768

G04CA02

ATC

tamsulosin; oral

1.5

20.2

955

7111

KC1GB

NOMESCO Finland

Cystography with X-ray

18.9

19.9

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

X76

ICPC

Malignant neoplasm breast female

+∞

19.8

1XC08

NOMESCO Finland

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

19.8

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

9.6

19.8

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.6

19.8

254

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

5.3

19.8

114

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.7

1271

10045

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

105.6

19.6

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

17.8

19.5

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

14.7

19.4

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

20.1

19.0

Z71.8

ICD-10 Finland

Other specified counselling

1.6

18.9

625

4288

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

18.8

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

18.8

ZX112

NOMESCO Finland

Subcutaneous

6.8

18.7

D17

ICPC

Incontinence of bowel

6.1

18.7

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.9

18.7

126

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.8

18.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

18.6

236

1202

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

18.4

233

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

18.4

437

2750

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

44.2

18.2

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

44.2

18.2

ZZR10

NOMESCO Finland

Flap of skin and muscle

17.6

18.2

R19.4

ICD-10 Finland

Change in bowel habit

3.2

18.0

313

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

33.0

17.9

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

33.0

17.9

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.4

17.9

102

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

26.8

17.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

17.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

17.7

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

17.7

LCD00

NOMESCO Finland

Hysterectomy

2.8

17.6

114

415

R03AC02

ATC

salbutamol; inhalant

0.7

17.6

961

12124

WX002

NOMESCO Finland

Sedation and analgesia

1.5

17.6

603

4166

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

95.5

17.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

17.5

530

7414

128

Kela drug reimbursment

Cancers of female genital organs

180.8

17.5

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

28.9

17.4

XKD00

NOMESCO Finland

Uroflowmetry

1.6

17.3

538

3628

GDC00

NOMESCO Finland

Lobectomy of lung

21.0

17.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

42.2

17.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.2

904

6835

JFB43

NOMESCO Finland

Left hemicolectomy

9.3

17.1

JKA20

NOMESCO Finland

Cholecystectomy

2.7

17.1

118

447

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.8

17.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

16.8

500

3335

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.4

16.8

141

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

16.7

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

16.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

16.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

90.5

16.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

170.7

16.5

K61.1

ICD-10 Finland

Rectal abscess

11.6

16.5

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.5

16.3

JAD10

NOMESCO Finland

Repair of incisional hernia

5.7

16.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.9

16.2

171

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.1

16.0

GDB10

NOMESCO Finland

Wedge resection of lung

21.0

16.0

S77

ICPC

Malignant neoplasm of skin

21.0

16.0

A28

ICPC

Limited function/disability NOS

1.5

15.9

527

3602

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

15.9

408

2619

K56.0

ICD-10 Finland

Paralytic ileus

4.6

15.9

122

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.9

15.6

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

15.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

+∞

15.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

160.6

15.5

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.3

15.4

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

38.2

15.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

15.3

248

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

15.3

458

3059

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

15.1

478

6658

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

20.1

15.1

ZXC40

NOMESCO Finland

Use of ultrasound

11.8

15.0

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.1

14.9

WX892

NOMESCO Finland

Monitored bed care

1.8

14.8

245

1375

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

14.6

L01BC04

ATC

carmofur; oral

+∞

14.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

14.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

80.4

14.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

14.5

117

485

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

150.5

14.5

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

36.2

14.4

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.9

14.3

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

17.0

14.3

JFB50

NOMESCO Finland

Other resection of colon

27.3

14.3

WGA11

NOMESCO Finland

Planning of pain management

22.3

14.2

R11

ICD-10 Finland

Nausea and vomiting

1.9

14.1

213

1158

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

14.1

151

718

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.2

14.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

14.0

122

527

KBH20

NOMESCO Finland

Replantation of ureter

23.8

13.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

13.7

448

6216

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

13.6

268

1594

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

75.4

13.6

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

75.4

13.6

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

13.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

13.5

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

13.5

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

34.1

13.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

140.5

13.4

K62.7

ICD-10 Finland

Radiation proctitis

140.5

13.4

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.2

13.4

JAL30

NOMESCO Finland

Omentectomy

12.8

13.4

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

18.3

13.3

SPAT1131

SPAT

Colonoscopy

2.4

13.3

112

477

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

11.0

13.0

JAG00

NOMESCO Finland

Repair of other hernia

16.7

13.0

R01AD09

ATC

mometasone; nasal

0.7

12.8

717

9123

UJF32

SPAT

3.6

12.8

161

JFF13

NOMESCO Finland

Terminal enterostomy

14.1

12.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

12.6

536

7122

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.6

12.6

153

L01EX05

ATC

regorafenib; oral

+∞

12.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

12.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

12.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

12.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

12.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

12.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

12.5

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

130.4

12.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

12.4

115

514

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

11.6

12.3

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.6

12.3

JJA20

NOMESCO Finland

Open biopsy of liver

14.4

12.2

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.5

12.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

12.2

174

931

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.3

12.1

104

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

18.1

12.0

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.7

12.0

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

46.8

11.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

11.8

111

499

K65.0

ICD-10 Finland

Acute peritonitis

3.8

11.8

126

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

5.6

11.7

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.9

11.7

JFA42

NOMESCO Finland

Endoscopic injection in colon

7.3

11.7

G47.3

ICD-10 Finland

Sleep apnoea

0.7

11.6

338

4806

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

5.4

11.6

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

22.9

11.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.2

11.5

116

537

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

11.5

1540A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]

+∞

11.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

11.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

11.5

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

11.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

11.5

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

11.5

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

11.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.5

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.9

11.4

115

KFC10

NOMESCO Finland

Bilateral orchiectomy

120.3

11.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

120.3

11.4

JF2CG

NOMESCO Finland

Extensive MRI of colon

120.3

11.4

GDB20

NOMESCO Finland

Segmental resection of lung

120.3

11.4

L02AE04

ATC

triptorelin; parenteral

120.3

11.4

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

11.3

249

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

15.1

11.3

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.8

11.3

A07DA03

ATC

loperamide; oral

2.1

11.2

121

577

R03DC03

ATC

montelukast; oral

0.6

11.2

162

2676

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

11.1

496

6556

L02BG03

ATC

anastrozole; oral

25.1

11.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

11.1

393

5395

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

11.1

204

1188

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

11.1

306

1996

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.1

11.0

ZX100

NOMESCO Finland

Oral

3.6

10.9

130

UJH02

NOMESCO Finland

Anoscopy

2.1

10.8

126

624

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.8

458

3288

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.6

10.8

127

2208

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

8.3

10.8

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.5

10.8

1682

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

17.8

10.7

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

17.8

10.7

Z93.8

ICD-10 Finland

Other artificial opening status

60.2

10.6

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

60.2

10.6

M25.5

ICD-10 Finland

Pain in joint

0.7

10.6

408

5527

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.3

10.6

424

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

7.0

10.5

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

10.5

223

1357

N05AX08

ATC

risperidone; systemic

0.5

10.5

1685

JFA70

NOMESCO Finland

Suture of small intestine

10.0

10.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

14.2

10.5

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.2

10.4

JFA86

NOMESCO Finland

Closure of fistula of colon

110.3

10.4

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

110.3

10.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

10.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

10.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

10.4

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

10.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

10.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

10.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

10.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

10.4

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

10.4

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

10.4

D74

ICPC

Malignant neoplasm stomach

+∞

10.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

10.4

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

10.4

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

10.4

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

10.4

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.6

10.4

126

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

10.3

197

1164

KA3EB

NOMESCO Finland

Antegrade pyelography

8.2

10.3

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

23.4

10.2

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

10.2

420

R19.5

ICD-10 Finland

Other faecal abnormalities

3.2

10.0

156

R18

ICD-10 Finland

Ascites

3.2

10.0

156

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

40.2

10.0

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

2010

9104

3.50

320.38

2.8

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2651

12814

4.36

307.65

5.9

3.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

451

359

14.08

307.65

5.3

1.8

u/ml

56.3

423.6

0.66

403

325

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2993

1710

72.79

307.65

10.1

1.4

ug/l

33.3

3.6

2.51

2743

1279

(4035726)

847

851

12.44

307.65

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1655

6524

3.68

307.65

3.3

2.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1074

2990

4.58

307.65

2.6

2.2

umol/l

7.9

8.3

0.21

998

2577

(3024561) Albumin [Mass/volume] in Serum or Plasma

2587

12839

4.03

307.65

11.3

3.9

g/l

32.9

35.3

74.12

2512

11685

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

862

603

18.08

307.65

6.3

1.8

u/ml

623.8

110.8

0.63

796

483

(3044640) Blood type and Crossmatch panel - Blood

2014

8478

3.85

307.65

3.5

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2842

14646

4.50

307.65

15.0

3.8

umol/l

11.2

12.3

4.74

2782

13672

(3022145) Colonoscopy Study observation

1623

2965

8.68

307.65

1.6

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1067

2280

6.07

307.65

2.4

2.0

g/l

0.2

3.20

1038

2049

(3032080) INR in Blood by Coagulation assay

2466

13372

3.31

278.66

8.9

11.2

inr

1.2

1.4

18.65

654

3660

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

868

2477

4.22

272.01

2.2

u/l

31.1

56.7

0.71

819

2079

(3002256) Pathology report gross observation

813

2210

4.39

271.91

1.3

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1095

4017

3.40

233.01

9.9

6.4

mmol/l

105.0

104.3

6.51

1083

3915

(3033658) Prothrombin time (PT) actual/Normal

1539

7076

2.94

219.35

5.1

3.6

89.9

84.4

14.91

1531

6886

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1864

9491

2.85

219.13

2.6

2.3

u/l

57.1

59.9

1.40

1797

8673

(3023368) Bacteria identified in Blood by Culture

1717

8641

2.77

202.43

5.3

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2568

15898

2.81

199.24

17.2

6.1

e9/l

3.9

4.4

22.99

2341

13561

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3148

22818

3.00

160.93

16.4

5.4

u/l

90.2

76.6

25.46

3066

21034

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1606

8768

2.42

148.12

4.5

2.6

u/l

32.1

36.2

1.12

1565

8212

(3037121) Protein [Mass/volume] in Urine

402

1023

4.27

142.51

6.6

2.6

g/l

0.2

0.3

4.34

314

363

(3012095) Magnesium [Moles/volume] in Serum or Plasma

966

4519

2.51

121.15

5.7

2.5

mmol/l

0.8

16.96

925

4121

(3015377) Calcium [Moles/volume] in Serum or Plasma

1623

9588

2.19

116.97

8.2

2.1

mmol/l

2.3

2.4

1.69

1488

7891

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1103

5556

2.37

116.87

9.7

2.2

mmol/l

2.5

2.4

16.41

1033

4733

(3003694) ABO and Rh group [Type] in Blood

1285

6934

2.27

115.62

1.4

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2567

18413

2.16

108.16

6.0

4.5

mmol/l

7.0

6.9

1.37

2485

17203

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

361

1048

3.69

105.54

2.7

3.1

u/ml

0.3

1.63

199

613

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

472

1650

3.12

102.49

9.2

9.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

539

2063

2.87

99.40

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2062

14016

2.00

95.54

7.4

5.4

mmol/l

1.2

14.28

1906

12358

(40758558) Short blood count panel - Blood

1197

6697

2.14

94.93

13.6

4.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

688

3092

2.49

91.50

8.3

7.6

g/l

117.4

122.3

9.11

665

2970

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2196

15459

1.97

89.67

8.4

5.8

mmol/l

1.2

17.51

1855

12960

(3002582) Erythrocytes [#/volume] in Urine

1496

9263

2.00

88.66

3.8

3.1

e6/l

107.0

76.0

0.38

1239

7049

(3016502) Oxygen saturation in Arterial blood

725

3442

2.36

84.81

8.0

7.1

96.9

95.0

13.30

698

3299

(3003396) Base excess in Arterial blood by calculation

770

3776

2.30

83.39

7.9

6.8

mmol/l

1.0

1.2

0.82

646

2892

(3027801) Oxygen [Partial pressure] in Arterial blood

772

3805

2.28

82.52

7.9

6.8

kpa

14.2

11.5

29.52

741

3613

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

772

3806

2.28

82.47

7.9

6.8

kpa

5.2

5.0

4.52

742

3620

(3031040) Bacteria [#/volume] in Urine by Automated count

2600

19722

1.96

81.33

5.2

4.4

e6/l

2160.9

2087.7

0.02

322

(36304419) Bacteria [Presence] in Urine

1326

8109

1.96

79.48

3.6

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

1367

8499

1.94

77.63

3.7

3.0

e6/l

0.5

0.4

0.74

1111

6326

(3014111) Lactate [Moles/volume] in Serum or Plasma

610

2806

2.39

76.02

6.1

6.5

mmol/l

1.3

1.4

1.22

587

2696

(3042936) Bacteria identified in Isolate by Culture

809

4263

2.13

72.23

2.3

2.0

—

(3026782) Osmolality of Urine

1014

5933

1.96

67.15

3.2

2.7

mosm/kgh2o

527.8

556.2

4.62

905

4950

(3018095) Leukocytes [#/volume] in Urine

1585

10695

1.81

67.03

4.4

3.5

e6/l

172.3

109.6

1.64

1282

7583

(3000850) Epithelial cells [#/volume] in Urine

1072

6439

1.92

65.37

2.9

2.5

e6/l

5.3

4.5

0.72

955

5553

(3026008) Bacteria identified in Urine by Culture

1377

9061

1.80

62.13

3.6

3.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

450

2016

2.39

58.67

8.5

8.7

95.2

93.4

10.13

450

2007

(3000991) Gas panel - Venous blood

527

2602

2.19

54.33

7.2

7.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

814

4834

1.86

49.47

3.6

2.8

e6/l

2.5

2.0

0.62

490

2649

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

746

4309

1.90

49.42

2.3

2.7

20.0

22.5

4.94

647

3601

(3020779) Urea [Moles/volume] in Serum or Plasma

553

2918

2.04

47.48

5.1

6.9

mmol/l

9.7

11.2

4.36

528

2750

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

242

890

2.83

47.03

1.3

1.2

—

(3039000) Anion gap in Blood

206

702

3.04

45.92

8.8

6.8

mmol/l

11.0

11.3

0.50

185

623

(3018572) Chloride [Moles/volume] in Blood

206

702

3.04

45.92

8.8

6.8

mmol/l

106.4

105.1

4.56

185

623

(3004789) Transferrin [Mass/volume] in Serum or Plasma

774

4625

1.84

45.71

2.2

2.6

g/l

2.3

2.11

729

4237

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

308

1308

2.47

44.80

1.9

1.8

ug/l

2.4

1.7

0.57

277

1122

(3025941) Bacteria identified in Stool by Culture

324

1417

2.40

44.16

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

816

5009

1.80

43.90

2.3

2.6

umol/l

11.4

12.7

5.91

768

4581

(3047181) Lactate [Moles/volume] in Blood

255

1005

2.64

43.30

7.8

6.0

mmol/l

1.4

1.3

0.25

224

883

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

355

1631

2.29

43.19

8.8

9.0

mmol/l

24.1

24.4

0.97

341

1486

(3037467) Urinalysis macro (dipstick) panel - Urine

2532

20848

1.61

42.02

5.7

4.2

—

(42870588) Differential panel, method unspecified - Blood

1370

9792

1.62

41.26

4.2

5.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

564

3164

1.91

40.13

5.0

3.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3339

29718

1.88

40.02

29.6

14.1

mg/l

37.4

25.0

63.01

3120

23416

(3018418) pH of Serum or Plasma

1261

8893

1.62

39.80

5.2

3.3

7.4

0.04

272

1552

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

831

5275

1.73

39.25

1.8

—

(3006504) Eosinophils/100 leukocytes in Blood

1742

13319

1.56

38.48

4.5

5.6

2.7

3.0

7.33

1617

12187

(3019069) Monocytes/100 leukocytes in Blood

1748

13381

1.56

38.36

4.7

5.9

9.1

8.9

1.12

1624

12288

(3022096) Basophils/100 leukocytes in Blood

1703

12966

1.56

38.26

4.5

5.6

0.6

0.7

14.91

1577

11884

(3002030) Lymphocytes/100 leukocytes in Blood

1771

13634

1.55

37.65

4.6

5.7

22.4

26.7

40.88

1625

12446

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

825

5297

1.71

37.13

3.3

2.6

e6/l

1.0

1.2

0.56

495

3087

(3019060) Gas panel - Arterial blood

435

2309

1.99

36.21

6.5

4.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1146

8083

1.59

35.25

2.2

2.3

mg/l

3.4

3.0

5.15

970

6802

(3008152) Bicarbonate [Moles/volume] in Arterial blood

420

2232

1.99

34.78

8.8

6.8

mmol/l

24.7

24.5

0.82

396

2070

(3018010) Neutrophils/100 leukocytes in Blood

1737

13505

1.52

34.10

4.4

5.5

61.3

58.2

17.31

1607

12405

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

297

1453

2.13

30.70

7.1

4.7

1.6

0.24

273

1361

(40768441) Liver Pathology biopsy report

5.72

30.33

1.1

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

291

1427

2.12

29.88

7.2

4.8

0.9

1.80

268

1337

(3048689) Calprotectin [Mass/mass] in Stool

500

2953

1.79

29.64

1.4

2.1

ug/g

278.8

161.5

4.48

396

2302

(3001604) Monocytes [#/volume] in Blood

1796

14356

1.47

29.07

4.3

5.3

e9/l

0.6

0.76

1523

12195

(3006315) Basophils [#/volume] in Blood

1807

14466

1.46

28.98

4.3

5.3

e9/l

0.0

14.49

1537

12309

(3003458) Phosphate [Moles/volume] in Serum or Plasma

624

3951

1.69

28.83

4.4

5.5

mmol/l

1.0

0.27

585

3617

(3051651) Icteric interference index of Serum or Plasma

142

4.71

28.69

5.1

4.1

—

(3019198) Lymphocytes [#/volume] in Blood

1829

14714

1.46

28.38

4.4

5.4

e9/l

1.6

1.8

2.79

1581

12711

(3013115) Eosinophils [#/volume] in Blood

1840

14946

1.44

26.39

4.5

5.4

e9/l

0.2

11.10

1599

12889

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

154

608

2.60

26.02

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

112

388

2.94

24.29

1.2

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

160

668

2.45

24.05

2.9

1.5

u/ml

43.2

25.9

1.24

155

633

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1467

11650

1.42

22.75

2.7

2.9

ug/l

168.2

145.5

0.88

1339

10572

(40768800) Prostate Pathology biopsy report

267

3.27

22.50

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

718

5018

1.53

21.39

2.1

1.9

30.3

30.1

0.31

702

4854

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

182

874

2.13

19.70

2.0

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3080

28101

1.46

19.63

30.6

13.2

ml/min/173m2

77.6

74.7

13.06

2794

22716

(3025468) Yersinia sp identified in Specimen by Organism specific culture

324

2.88

19.43

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

333

2.84

19.06

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

323

2.86

18.96

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

333

1986

1.74

18.78

1.8

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

326

2.83

18.64

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

339

2.79

18.45

1.4

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

519

3480

1.57

18.43

1.8

—

(3021589) Normoblasts [#/volume] in Blood

1550

12736

1.36

18.37

16.3

8.8

e9/l

0.0

0.08

1282

10312

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

329

2.81

18.34

1.4

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

481

3208

1.57

17.44

3.0

2.7

u/l

266.7

239.5

1.54

459

2967

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2761

29991

0.72

17.18

4.2

4.9

mmol/l

4.5

1.06

2483

27449

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2733

29729

0.73

17.10

4.2

4.8

mmol/l

1.4

0.74

2444

27017

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2075

17973

1.33

16.64

3.6

3.0

u/l

66.6

50.7

7.44

1946

16295

(3044889) 12 lead EKG panel

2466

21914

1.34

16.52

4.5

4.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

234

1313

1.83

16.21

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

533

3697

1.51

16.09

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

388

2.54

16.06

5.3

6.4

mg/l

12.1

0.02

350

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

160

3.47

16.02

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

302

2.75

16.00

4.9

3.6

—

(3012501) Base excess in Blood by calculation

142

674

2.15

15.88

4.4

4.5

mmol/l

2.6

0.04

102

445

(3019550) Sodium [Moles/volume] in Serum or Plasma

3378

31707

1.50

15.66

35.8

17.3

mmol/l

139.2

139.8

33.99

3325

30803

(40761536) Microorganisms panel - Urine sediment

361

2312

1.62

15.47

4.6

4.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3383

31785

1.49

15.38

35.8

17.4

mmol/l

4.0

19.01

3329

30830

(40761511) CBC panel - Blood by Automated count

3281

30648

1.45

15.33

30.1

13.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2856

30732

0.73

15.31

4.7

5.5

mmol/l

2.6

0.33

2542

28018

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

529

3704

1.50

15.21

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

305

1888

1.67

14.95

1.5

—

(3010421) pH of Blood

158

802

2.01

14.80

4.2

4.3

7.4

0.57

141

660

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2669

28969

0.75

14.77

6.1

6.6

mmol/mol

41.2

41.0

0.46

2393

26534

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

135

653

2.11

14.41

2.4

2.2

219.2

196.5

1.97

130

619

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

312

4790

0.62

14.41

1.2

1.3

iu/ml

70.6

39.9

1.24

1438

(3021447) Carbon dioxide [Partial pressure] in Venous blood

464

3218

1.50

13.92

3.0

3.5

kpa

5.7

5.8

1.61

450

3115

(3002032) Base excess in Venous blood by calculation

461

3200

1.50

13.76

3.0

3.5

mmol/l

2.0

1.9

0.04

362

2584

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

296

4551

0.62

13.71

1.2

u/ml

12.0

14.4

0.24

104

1659

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

212

1217

1.78

13.64

1.9

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

132

647

2.08

13.63

2.4

2.5

umol/l

35.0

35.3

0.04

112

546

(3018405) Lactate [Moles/volume] in Arterial blood

221

1285

1.76

13.61

4.9

3.9

mmol/l

1.2

1.4

2.09

215

1258

(3013512) EKG study

1204

9853

1.32

13.56

4.2

4.3

—

(3019225) pH of Specimen

458

3201

1.49

13.20

4.2

3.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

156

823

1.93

13.11

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

156

828

1.92

12.89

1.2

—

(40768795) Lymph node Pathology biopsy report

4.70

12.81

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

134

3.38

12.71

2.9

1.6

nmol/l

9.1

4.5

0.43

128

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

154

819

1.92

12.65

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

377

2.36

12.65

2.5

3.0

3.4

1.5

2.17

279

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

368

2484

1.53

12.51

4.8

3.1

mmol/l

1.2

1.77

327

2107

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2666

28759

0.77

12.51

3.8

4.3

mmol/l

1.3

0.08

2362

25898

(3052851) Hemolysis interference index of Serum or Plasma

161

882

1.86

12.09

5.0

3.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

527

3860

1.42

11.82

2.2

2.1

1.8

0.24

471

3356

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

245

1524

1.65

11.79

2.5

4.0

mmol/l

24.1

0.01

229

1341

(4281824)

136

3.26

11.74

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

127

3.33

11.61

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

127

3.33

11.61

1.3

1.2

—

(40768793) Breast Pathology biopsy report

143

3.17

11.49

1.4

1.2

—

(3049717) Cytology report of Urine Cyto stain

191

1121

1.74

11.42

2.8

1.8

—

(1616796) Gas panel - Central venous blood

133

702

1.93

11.21

3.6

3.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

172

2.93

11.16

1.2

1.3

—

(3020891) Body temperature

230

1429

1.65

11.13

5.4

4.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

346

2.31

10.85

1.1

g/l

1.6

1.5

1.17

300

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3349

31794

1.38

10.76

19.3

9.5

u/l

24.1

25.7

7.08

3279

30305

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

177

2.85

10.62

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

269

1780

1.55

10.01

2.4

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

2579

23744

1.26

9.79

39.5

16.9

14.6

13.7

85.94

2545

23070

(3009542) Hematocrit [Volume Fraction] of Blood

2774

25865

1.25

8.85

31.6

15.7

37.5

39.4

19.21

1781

16416

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

678

8398

0.77

8.81

1.6

1.7

mmol/l

1.5

1.3

1.57

551

6933

(3036489) Thrombin time

160

965

1.69

8.73

2.1

1.8

20.9

21.2

0.41

152

849

(3043410) Blood group antigens tested for on Red Blood Cells

3.62

8.54

2.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

442

1.99

8.29

1.3

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

491

1.94

8.27

3.8

3.5

59.8

58.7

0.30

491

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

113

628

1.82

8.22

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

264

3735

0.69

7.99

1.2

1.3

titre

586.4

533.8

0.13

795

(3013707) Erythrocyte sedimentation rate by Westergren method

2438

22527

1.22

7.95

3.4

4.1

mm/h

16.7

12.7

20.32

2223

20624

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.71

7.89

1.3

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

174

1102

1.61

7.87

1.2

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

326

2359

1.42

7.77

3.2

3.7

1.2

0.8

2.08

131

520

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

345

2524

1.40

7.72

4.6

2.4

ml/min/173m2

61.4

62.4

0.17

141

981

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2036

22174

0.83

7.68

3.2

3.7

pmol/l

15.0

0.16

1781

19760

(3023520) Reticulocytes [#/volume] in Blood

391

2931

1.37

7.56

2.3

2.2

e9/l

69.0

68.1

0.18

298

2254

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

170

2.55

7.49

1.7

1.9

u/field

3.4

1.9

0.67

117

(3024354) Oxygen [Partial pressure] in Venous blood

361

2682

1.38

7.37

2.9

3.0

kpa

4.5

0.02

347

2586

(3024731) MCV [Entitic volume]

3411

32810

1.32

7.34

45.7

20.7

91.4

91.6

1.77

3370

32138

(3035941) MCH [Entitic mass]

3411

32812

1.32

7.32

45.6

20.6

30.2

30.5

18.66

3369

32142

(3026361) Erythrocytes [#/volume] in Blood

3411

32814

1.32

7.30

45.8

20.7

e12/l

4.3

4.5

131.39

3343

31569

(3010813) Leukocytes [#/volume] in Blood

3411

32818

1.32

7.26

45.9

20.8

e9/l

6.7

6.8

1.07

3343

31576

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

110

2.92

7.26

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

110

2.92

7.26

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

110

2.92

7.26

1.4

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3411

32819

1.32

7.25

46.1

20.9

g/l

127.1

136.3

196.66

3368

32153

(3021440) Promyelocytes/100 leukocytes in Blood

313

2277

1.41

7.24

3.2

3.7

0.2

0.1

1.42

121

487

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.31

7.23

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

4.30

7.20

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

388

1.98

7.19

1.4

1.5

g/l

30.4

28.3

0.74

336

(3007461) Platelets [#/volume] in Blood

3409

32805

1.32

7.17

45.9

20.7

e9/l

248.2

239.9

9.08

3345

31708

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

307

2.10

7.17

1.3

1.4

pmol/l

240.0

80.8

0.79

296

(3021601) Nitrite [Presence] in Urine by Test strip

1647

14765

1.20

7.01

5.6

5.0

estimate

0.0

0.50

382

2547

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

287

2071

1.42

6.96

3.1

3.6

mmol/l

2.1

1.8

0.40

207

1490

(3043409) Potassium [Moles/volume] in Arterial blood

168

1091

1.56

6.88

5.3

4.3

mmol/l

3.8

3.9

3.51

158

1024

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

105

604

1.76

6.87

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2848

29928

0.82

6.82

4.5

5.1

mmol/l

6.2

6.1

1.22

2532

26897

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

110

2.83

6.67

1.4

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

959

8191

1.23

6.67

4.5

4.1

estimate

0.0

0.35

332

2454

(40767503) Oxygen content in Capillary blood by calculation

115

686

1.70

6.63

2.8

2.5

15.1

16.2

1.48

379

(3026493) Urate [Moles/volume] in Serum or Plasma

725

8651

0.80

6.62

2.5

2.6

umol/l

2292.2

5777.0

2.30

616

7307

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

674

5547

1.26

6.57

1.1

1.2

u/ml

1.6

2.1

0.56

169

1434

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

302

2223

1.39

6.54

1.3

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

177

1177

1.53

6.53

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

295

2167

1.39

6.47

3.1

3.6

kpa

5.1

5.2

0.69

273

1977

(3028308) Erythrocytes [#/volume] in Pleural fluid

307

2.04

6.43

1.4

1.5

e6/l

22143.4

74987.1

1.11

178

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.14

6.43

1.4

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.14

6.43

1.4

1.2

—

(3009343) pH of Capillary blood

291

2136

1.39

6.41

3.1

3.6

7.4

0.02

262

(3035350) Ketones [Presence] in Urine by Test strip

1638

14772

1.19

6.30

4.2

3.7

estimate

0.0

0.50

373

2506

(3022217) INR in Platelet poor plasma by Coagulation assay

620

5079

1.26

6.27

20.6

29.9

inr

1.3

1.5

2.29

659

(3009261) Glucose [Presence] in Urine by Test strip

1655

14946

1.19

6.25

4.3

3.7

estimate

0.0

1.34

374

2433

(3012441) Differential panel - Pleural fluid

291

2.04

6.19

1.4

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

789

6649

1.23

6.19

3.4

4.1

ng/l

544.7

490.3

0.10

653

5633

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

252

2.12

6.13

1.2

1.3

u/l

303.6

273.7

0.20

237

(3023199) Leukocytes [#/volume] in Pleural fluid

341

1.95

6.10

1.4

1.5

e6/l

832.0

2088.2

1.24

245

(3002179) Metamyelocytes/100 leukocytes in Blood

292

2167

1.38

6.03

2.9

3.6

0.7

0.6

0.33

388

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

676

1.66

5.96

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

111

676

1.66

5.96

1.2

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1472

13199

1.18

5.95

3.7

4.0

ng/l

34.2

82.1

2.54

1177

9924

(3033799) Differential panel - Peritoneal fluid

3.12

5.88

2.6

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

2.59

5.87

2.0

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

399

1.84

5.72

1.9

1.8

88.6

89.7

0.66

393

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

220

1571

1.42

5.70

1.6

1.5

g/l

1.7

1.5

1.68

189

1346

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

12.88

5.57

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

116

733

1.60

5.41

3.1

2.9

kpa

7.9

7.8

0.22

111

679

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.80

5.13

1.8

2.9

e6/l

700.9

648.7

0.05

(3017354) Segmented neutrophils/100 leukocytes in Blood

252

2.00

5.02

2.4

2.7

59.1

59.6

0.06

159

(4010399)

167

2354

0.70

4.98

1.3

1.4

—

(3025159) Blasts/100 leukocytes in Blood

284

2165

1.34

4.97

3.3

3.8

0.6

0.3

0.23

428

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.04

4.94

1.3

2.1

g/l

11.7

15.1

1.25

(3041096) Erythrocytes [Presence] in Urine by Automated

865

7511

1.19

4.88

4.7

3.4

—

(3021901) Oxygen saturation in Capillary blood

101

635

1.61

4.85

3.0

2.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

942

10683

0.84

4.83

2.1

2.2

u/l

207.3

231.0

0.37

882

9948

(3044007) Cell count panel - Peritoneal fluid

2.99

4.82

2.1

2.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

229

2.02

4.79

1.3

1.4

—

(4094501)

900

0.53

4.78

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.75

4.77

1.3

1.4

1.2

2.6

0.97

(40768806) Pleura Pathology biopsy report

271

1.93

4.76

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.89

4.75

1.9

2.7

e6/l

21072.0

31331.9

0.12

(3000570) Elastase.pancreatic [Mass/mass] in Stool

125

830

1.52

4.74

1.3

1.4

ug/g

249.8

286.0

1.29

508

(3017143) Hepatitis C virus Ab [Presence] in Serum

278

2129

1.33

4.72

1.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

397

1.75

4.64

2.0

5.3

iu/ml

238.3

434.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

288

1.89

4.63

2.7

3.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

564

4742

1.22

4.45

1.4

1.3

g/l

2.7

0.12

317

2683

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

222

1.99

4.44

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

222

1.99

4.44

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

222

1.99

4.44

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1288

0.62

4.40

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.62

4.39

3.7

2.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

679

5822

1.20

4.37

4.1

4.2

—

(3045142) Bone marrow Pathology biopsy report

231

1.96

4.34

1.2

1.1

—

(1002224) Polysomnography panel

910

0.55

4.33

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

418

3415

1.25

4.31

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

289

1.84

4.27

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

261

1.89

4.25

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

133

1884

0.70

4.13

2.2

2.4

au/ml

64.4

27.4

—

(3008898) HLA-B27 [Presence]

687

0.50

4.08

1.1

—

(3022313) Gas panel - Capillary blood

205

1543

1.35

3.96

3.0

3.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

184

2.02

3.92

1.3

u/l

9.6

10.3

0.21

163

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.64

3.92

2.6

1.1

ug/l

0.8

2.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

102

679

1.52

3.89

1.8

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

125

2.25

3.89

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

125

2.25

3.89

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

270

1.82

3.86

3.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

802

0.56

3.85

1.3

1.7

mg/l

2.9

4.0

0.39

565

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

928

0.59

3.85

1.1

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

113

779

1.46

3.66

1.6

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1038

0.62

3.65

1.2

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

455

0.44

3.57

4.0

4.3

umol/l

340.9

348.8

0.08

386

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

589

1.52

3.52

1.2

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

112

2.24

3.47

1.8

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.34

3.47

1.7

2.7

—

(1761868) Lipid panel - Serum or Plasma

819

9180

0.86

3.44

3.0

3.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2639

27446

0.88

3.41

3.9

4.5

mu/l

2.1

0.02

2316

24606

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

160

2.01

3.39

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

5.01

3.36

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

176

1331

1.34

3.35

3.1

4.0

mmol/l

24.8

24.7

0.07

157

1206

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

161

2.00

3.33

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

383

1.63

3.31

1.3

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

254

0.35

3.29

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

124

889

1.41

3.29

3.2

3.1

mmol/l

24.0

24.9

1.11

111

785

(3020682) Albumin/Creatinine [Ratio] in Urine

1062

11652

0.88

3.25

4.2

4.0

mg/mmol

10.7

8.5

0.94

694

7448

(3027273) Bicarbonate [Moles/volume] in Venous blood

228

1796

1.29

3.24

3.6

3.1

mmol/l

24.5

25.2

1.92

217

1731

(3024891) Influenza virus A+B Ag [Presence] in Specimen

642

1.48

3.23

1.1

1.2

—

(4034850)

1138

0.66

3.22

12.5

10.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

209

1629

1.30

3.22

2.4

2.6

0.7

0.03

200

1554

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1099

0.66

3.18

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

273

2207

1.25

3.14

2.8

3.1

g/l

123.7

130.6

5.85

266

2140

(3006184) Hemoglobin [Mass/volume] in Capillary blood

109

775

1.42

3.05

2.7

2.2

g/l

121.3

130.1

2.91

579

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

384

1.60

3.05

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1004

11015

0.88

3.03

3.4

3.2

mg/l

298.0

224.3

0.26

687

7103

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

239

2960

0.79

2.99

1.5

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1194

10964

1.13

2.98

2.6

3.2

ng/l

1528.0

1601.8

0.27

1054

9477

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

442

1.55

2.97

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1.85

2.96

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

107

2.16

2.96

1.2

1.4

46.6

64.3

1.04

(3035880) pH of Pleural fluid

148

1.97

2.94

1.2

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1023

11187

0.88

2.91

3.3

3.2

mmol/l

7.4

7.5

0.33

824

9308

(3005322) IgE [Units/volume] in Serum or Plasma

116

1577

0.73

2.91

1.2

1.3

u/ml

223.6

239.1

0.08

103

1451

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

281

1.68

2.88

1.7

2.1

u/field

2.6

1.8

0.43

105

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1062

0.67

2.87

1.2

u/ml

7.4

0.7

—

107

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

215

1.77

2.83

1.1

—

(40765096) Chromosome analysis panel by Banding

2.86

2.74

1.2

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

203

1.78

2.72

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

320

1.60

2.63

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

108

1457

0.73

2.61

1.2

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.67

2.59

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

245

1.68

2.56

1.9

1.3

—

(3019977) pH of Arterial blood

193

1.77

2.53

1.8

2.1

7.4

0.30

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

0.34

2.53

1.8

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

868

0.66

2.53

1.2

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

165

1298

1.28

2.44

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

336

0.47

2.41

1.3

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

823

0.66

2.41

1.4

1.6

iu/ml

1.2

3.7

0.35

188

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

626

1.40

2.35

1.0

1.1

u/ml

1.3

7.7

—

(3024928) Oxygen saturation in Venous blood

704

1.37

2.32

1.4

3.1

—

(3014891) Appearance of Pleural fluid

2.69

2.27

2.3

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

615

0.63

2.21

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

492

1.43

2.18

1.2

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

265

1.59

2.17

1.8

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

699

6329

1.13

2.15

1.6

1.7

mg/l

2.2

1.3

3.59

570

4884

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

1.47

2.11

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

995

0.72

2.09

1.2

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

311

2668

1.18

2.05

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1221

11422

1.10

2.04

4.7

4.0

—

(3045414) Leukocytes [Presence] in Urine

171

1387

1.24

2.01

2.4

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

376

3285

1.16

1.98

2.5

3.1

ng/l

240.2

227.5

0.22

337

3019

(44816559) Phosphatidylethanol [Mass/volume] in Blood

487

0.61

1.96

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

204

1.62

1.88

2.2

1.7

—

(3014271) Vancomycin [Susceptibility]

204

1.62

1.88

2.9

3.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

625

0.67

1.86

1.0

1.3

e6/l

4.2

26.6

1.32

487

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

625

0.67

1.86

1.2

1.4

e6/l

214.6

889.8

1.61

513

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

613

0.67

1.86

1.1

1.3

—

(3042631) Mycobacterium sp identified in Specimen

408

1.43

1.85

1.8

3.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

3.53

1.83

9.8

1.2

—

(3000012) Reticulocyte production index

175

1.66

1.82

1.3

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

877

0.73

1.80

1.5

e6/l

8359.2

14490.0

1.05

638

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.05

1.79

1.9

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

176

1.65

1.79

2.3

2.4

—

(3002619) Bacteria identified in Specimen by Culture

2.34

1.77

1.5

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

146

1.72

1.77

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

150

0.40

1.76

1.2

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

699

0.70

1.76

1.2

u/ml

2.1

5.0

—

117

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

268

3101

0.85

1.74

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

271

0.51

1.74

1.1

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

217

0.46

1.72

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

139

1706

0.81

1.72

1.8

1.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

741

0.71

1.70

1.2

—

49.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.38

1.67

1.0

1.2

ng/l

82.6

156.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

966

0.75

1.66

2.6

2.2

ug/min

204.2

114.6

0.47

557

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.16

1.66

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

165

1.64

1.4

u/l

13.9

5.8

0.78

(3028707) Methadone [Presence] in Urine by Screen method

148

0.40

1.63

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

294

1.47

1.62

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

261

0.53

1.57

1.0

u/ml

2.6

3.5

—

118

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

137

1.68

1.55

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

137

1.68

1.55

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

398

1.39

1.54

8.6

25.1

mmol/l

6.8

7.7

1.86

324

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

552

0.69

1.54

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

265

1.48

1.53

1.1

1.2

u/l

100.4

58.1

0.41

167

(3039443) Prostate specific Ag panel - Serum or Plasma

654

0.71

1.50

1.4

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

125

0.40

1.49

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

256

0.55

1.48

1.0

u/ml

1.8

0.9

—

100

(3044242) Glucose [Moles/volume] in Arterial blood

202

1.54

1.48

2.3

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.22

1.46

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.50

1.45

1.1

—

(3045424) Erythrocytes [Presence] in Urine

507

1.33

1.44

1.8

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

156

1.61

1.43

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

188

1.55

1.42

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

224

1939

1.16

1.40

4.1

3.2

e9/l

4.2

4.1

0.14

171

1358

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.87

1.34

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

247

0.57

1.34

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

195

0.51

1.32

2.1

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

306

0.62

1.29

1.0

1.1

u/ml

1.6

1.4

—

117

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

409

4497

0.90

1.27

12.1

7.4

—

(3014051) Protein [Presence] in Urine by Test strip

732

1.25

1.26

2.7

2.1

—

(3024263) Appearance of Synovial fluid

203

0.54

1.24

1.3

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.77

1.22

1.3

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.91

1.22

1.6

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

204

1.47

1.22

2.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

—

(3011288) Drugs identified in Urine by Screen method

201

0.55

1.20

1.0

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

156

1.54

1.19

1.3

—

(36660697) Celiac disease serology panel - Serum

232

2042

1.14

1.19

1.1

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.83

1.19

1.3

1.5

17.9

27.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

197

1.48

1.19

2.0

2.1

ug/min

64.8

220.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

894

0.79

1.18

1.4

1.7

—

(3016879) Cocaine [Presence] in Urine

298

0.64

1.17

1.2

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.93

1.16

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

126

0.48

1.16

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

2.00

1.16

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2.00

1.16

1.2

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

1.16

0.0

1.2

—

10.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

100

1209

0.82

1.15

1.7

u/l

37.9

38.0

0.02

1011

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

257

1.40

1.15

1.0

u/ml

4.1

2.6

0.33

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

332

0.66

1.14

1.3

1.4

46.6

27.2

1.06

220

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

296

0.64

1.14

1.1

—

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

608

1.25

1.13

1.3

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

103

1.65

1.12

1.2

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

111

1.62

1.11

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1007

0.81

1.11

3.3

1.5

g/l

0.0

1.08

916

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.96

1.11

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.96

1.11

1.2

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

572

0.75

1.10

1.1

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.82

1.08

1.3

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

140

0.50

1.08

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

915

0.80

1.07

3.1

1.5

g/l

0.0

0.00

838

(4146454)

417

1.30

1.07

3.4

2.8

—

(3027008) Opiates [Presence] in Urine

314

0.67

1.06

1.2

1.6

—

(3025130) Human papilloma virus identified in Specimen

145

1.52

1.05

1.5

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

121

0.49

1.05

2.8

2.7

umol/l

29.2

29.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

746

0.79

1.05

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

441

0.72

1.04

1.3

1.5

54.6

63.0

0.44

292

(3010144) Erythrocytes [#/volume] in Synovial fluid

348

0.69

1.04

1.3

1.2

e6/l

91264.0

242296.5

0.85

245

(3042111) Morphology [Interpretation] in Bone marrow Narrative

419

1.29

1.04

1.8

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

162

1.48

1.03

2.3

1.4

u/l

216.1

2352.6

0.76

(3005033) Fetal Nuchal fold Thickness US

1.96

1.03

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.92

1.02

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.88

1.00

1.3

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

197

1.42

0.99

3.9

3.3

13.3

0.09

197

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

740

0.79

0.99

1.8

1.9

mg/l

11.1

11.9

0.31

674

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

132

0.53

0.98

1.0

1.2

—

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.17

0.98

10.6

13.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.17

0.98

1.0

—

5.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.97

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.97

0.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

284

0.67

0.97

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

771

0.80

0.97

1.6

1.8

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

74.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

604

0.78

0.97

1.1

1.2

—

10.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.74

0.96

1.1

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

933

0.82

0.95

3.1

1.5

g/l

0.0

0.00

843

(3021788) Differential panel - Synovial fluid

635

0.78

0.94

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

1.78

0.94

1.5

—

(3022621) pH of Urine by Test strip

231

2072

1.12

0.93

3.4

3.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

117

1.54

0.93

1.7

2.1

92.6

94.8

0.10

109

(3028300) Cannabinoids [Presence] in Urine

316

0.69

0.93

1.2

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

776

7351

1.07

0.93

3.4

3.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

365

1.29

0.92

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

391

4230

0.92

4.3

5.0

32.9

0.02

257

2797

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

280

0.68

0.92

1.1

—

27.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.82

0.92

1.3

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

1360

0.86

0.92

2.7

1.4

g/l

3.8

0.33

955

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

565

0.78

0.91

1.8

1.7

iu/l

6.4

4.5

0.27

171

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

1271

0.85

0.89

2.5

1.4

g/l

10.5

10.3

0.14

1053

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1527

14777

1.05

0.89

4.6

4.0

ug/l

2.7

2.4

0.47

1316

13213

(3000764) Benzodiazepines [Presence] in Urine

313

0.70

0.89

1.2

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

0.48

0.89

1.0

—

(4015189)

104

0.48

0.88

1.4

2.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

105

0.48

0.88

1.0

1.2

u/ml

—

11.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

1364

0.86

0.87

2.7

1.4

g/l

7.4

7.5

0.17

993

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

1364

0.86

0.87

2.7

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.00

0.87

1.0

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

856

8157

1.06

0.86

1.7

1.6

nmol/l

19.8

20.2

0.24

736

6871

(3027944) Amphetamines [Presence] in Urine

309

0.71

0.84

1.2

1.6

—

(3011648) Oxygen content in Venous blood

248

1.33

0.83

1.1

1.9

10.8

11.0

0.15

248

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

0.58

0.83

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.74

0.82

2.5

2.7

u/field

0.5

0.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.88

0.81

1.0

1.1

—

(3004451) EKG impression Narrative

180

1.39

0.81

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.65

0.81

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.79

0.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.6

—

0.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

148

0.61

0.79

1.3

1.8

—

12.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1073

0.85

0.78

2.7

1.4

g/l

37.5

37.6

0.04

889

(3036603) Volume of Urine

173

1.39

0.78

2.0

1.3

1781.0

1945.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1136

0.86

0.77

2.9

1.5

g/l

0.6

0.5

0.11

963

(3025018) Bordetella pertussis Ab [Titer] in Serum

126

0.55

0.77

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

439

0.77

2.4

2.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

368

1.25

0.75

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.54

0.75

1.1

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.08

0.74

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

578

1.20

0.74

1.5

1.3

mmol/l

71.0

63.5

0.58

462

(3005719) IgG [Mass/volume] in Serum or Plasma

206

1867

1.11

0.74

2.5

2.2

g/l

9.8

10.8

3.07

188

1703

(3019150) Specific gravity of Urine by Refractometry

657

6904

0.94

0.73

4.2

kg/l

1.0

0.27

104

1022

(40760888) Immunoglobulin light chains.free panel - Serum

801

1.16

0.73

2.5

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

1055

1.14

0.71

2.0

2.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

264

0.72

0.71

1.2

1.3

—

23.9

—

(3000492) Spirometry study

233

2539

0.91

0.69

1.4

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.53

0.68

2.5

2.3

mmol/l

8.7

8.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

239

0.71

0.68

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

1.46

0.68

1.4

1.7

umol/l

102.1

150.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.63

0.66

1.7

1.3

—

(4212803)

1.79

0.66

1.0

—

(3023410) Appearance of Cerebral spinal fluid

260

0.73

0.66

1.2

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

394

1.22

0.65

1.2

1.3

iu/l

44.8

31.7

1.50

344

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

1.31

0.65

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

1274

0.88

0.64

2.7

1.4

g/l

3.1

3.0

0.20

977

(3004775) Volume in Urine collected for unspecified duration

314

0.76

0.63

1.8

2.3

653.4

631.7

0.14

201

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

222

0.72

0.61

1.1

1.2

mmol/l

2.7

2.1

0.70

208

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

361

1.22

0.61

1.2

1.4

u/ml

78.5

110.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

576

0.83

0.61

1.1

1.2

u/l

51.2

30.3

0.47

500

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

390

0.79

0.61

1.1

1.2

miu/ml

322.3

200.6

—

144

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

105

1.43

0.60

2.1

1.2

umol/l

39.2

8.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

126

1403

0.89

0.59

1.2

iu/ml

176.9

131.0

0.55

512

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

408

1.20

0.59

1.6

2.1

mg/l

48.7

26.4

0.54

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.59

0.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

519

1.18

0.59

3.2

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.44

0.58

1.6

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

107

950

1.13

0.58

5.0

4.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

264

2835

0.93

0.58

1.5

1.7

1.6

0.15

226

2392

(3024869) Neuronal Ab [Presence] in Serum

1.56

0.58

1.0

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.58

0.0

1.2

—

(3044941) Cell count panel - Synovial fluid

562

0.83

0.58

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

246

1.26

0.58

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

409

0.80

0.58

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

114

0.61

0.58

1.1

1.2

40.7

57.8

—

101

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

158

1.33

0.57

2.4

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

274

1.24

0.56

2.1

1.7

—

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.58

0.54

1.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.58

0.54

1.3

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

249

1.25

0.53

1.0

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

181

0.72

0.52

1.4

1.9

nmol/l

16.8

15.5

0.22

161

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

187

1.28

0.52

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1160

11913

0.96

0.52

4.1

3.9

20.5

24.2

14.50

571

5955

(3016650) Hepatitis A virus Ab [Presence] in Serum

341

1.20

0.52

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.40

0.51

1.6

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.40

0.51

1.6

2.4

—

(3045716) Anion gap in Serum or Plasma

188

1.28

0.51

2.7

2.1

mmol/l

9.0

9.6

0.43

146

(3002523) Influenza virus A Ag [Presence] in Specimen

251

1.24

0.50

1.0

1.1

—

(44790047)

297

1.21

0.50

1.3

1.4

—

(44806118)

297

1.21

0.50

1.3

1.4

—

(44790048)

297

1.21

0.50

1.3

1.4

—

(44790049)

297

1.21

0.50

1.3

1.4

—

(40768797) Stomach Pathology biopsy report

433

4125

1.06

0.49

1.3

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.3

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.56

0.49

1.3

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

418

1.17

0.48

1.2

—

(3022689) Creatine [Moles/volume] in Urine

107

0.65

0.48

1.3

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.52

0.48

1.4

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

299

1.21

0.47

1.1

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1457

14261

1.03

0.46

2.1

pmol/l

86.4

93.2

6.86

857

7444

(3004588) Protein electrophoresis panel - Serum or Plasma

225

2403

0.93

0.46

2.5

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

804

8293

0.96

0.46

3.0

2.8

ug/l

0.7

0.07

561

5803

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.62

0.45

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

450

0.84

0.45

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

119

0.67

0.45

1.0

1.5

—

(44813793)

164

0.73

0.45

1.1

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

714

1.12

0.44

2.4

2.7

mg/l

1.9

1.7

0.80

627

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

119

1086

1.10

0.44

2.7

1.6

mg/l

36.1

42.6

0.51

880

(21494434) Karyotype in Bone marrow

247

1.22

0.44

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

508

1.14

0.43

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.43

0.42

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

119

1089

1.10

0.42

2.7

1.6

mg/l

53.7

50.9

0.17

100

887

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.8

—

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

0.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

482

1.14

0.41

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

304

0.82

0.40

1.0

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

370

1.16

0.40

1.3

1.2

u/ml

3.3

5.7

1.22

167

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

101

0.69

0.39

1.0

1.5

mmol/l

-1.1

0.2

—

(4133840)

1.41

0.39

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

151

1.26

0.38

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

0.75

0.38

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.39

0.38

2.4

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.39

0.38

2.4

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

401

1.15

0.37

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

213

0.80

0.36

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

267

0.82

0.36

1.9

2.0

ug/l

2.2

1.9

0.28

224

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

128

1378

0.93

0.36

3.1

2.9

pmol/l

4.3

4.4

0.74

121

1187

(3024471) HLA-A [Type]

0.64

0.35

1.0

—

(4062490)

266

0.83

0.35

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

208

1.20

0.35

1.5

1.2

mmol/l

11.7

12.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

309

0.84

0.35

2.0

1.7

u/ml

32.2

24.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

114

1054

1.08

0.34

2.7

1.5

ratio

1.4

2.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

250

2376

1.06

0.34

1.8

nmol/l

410.9

366.8

2.73

232

2142

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.37

0.34

1.1

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.37

0.34

1.2

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

200

0.80

0.34

1.3

u/ml

0.2

1.3

—

100

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

189

0.79

0.34

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

189

0.79

0.34

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

189

0.79

0.34

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

720

0.90

0.34

3.8

3.7

mg/l

35.7

28.8

0.56

470

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

127

1.26

0.33

1.1

1.3

—

(3034426) Prothrombin time (PT)

0.69

0.33

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.68

0.33

1.2

1.5

ug/l

10.4

9.1

—

(3051593) INR in Capillary blood by Coagulation assay

210

1.19

0.32

5.9

10.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

455

1.12

0.31

4.0

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

369

0.87

0.31

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

105

1130

0.93

0.31

1.6

titre

193.3

284.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

186

0.81

0.31

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

186

0.81

0.31

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

186

0.81

0.31

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

1972

0.95

0.30

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

100

0.70

0.30

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

463

0.88

0.30

1.1

iu/ml

193.3

447.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.30

0.30

1.3

1.9

18.4

8.9

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.30

0.30

1.3

1.8

25.9

26.5

—

(3048879) Bone marrow aspiration report

1.33

0.30

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

162

0.80

0.28

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

129

0.77

0.28

2.2

umol/l

59.1

57.6

—

104

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

792

0.92

0.27

1.4

1.5

g/l

0.3

0.2

0.72

753

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

311

0.87

0.27

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

113

1.24

0.26

1.1

2.1

18.9

15.5

—

(3044927) Protein electrophoresis panel - Urine

405

0.89

0.26

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.68

0.26

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.67

0.25

3.6

7.5

—

(4211845)

160

1.19

0.25

4.4

3.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

114

1.23

0.25

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

378

1.11

0.24

1.3

1.2

u/ml

5.1

3.5

0.24

113

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

276

0.87

0.24

1.0

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

723

7081

1.03

0.24

1.7

1.8

nmol/l

1158.3

1147.0

0.11

555

5291

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.73

0.24

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

207

1984

1.05

0.24

2.0

2.2

nmol/l

10.5

14.6

8.36

172

1719

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.71

0.24

1.0

1.1

—

30.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

317

0.88

0.23

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

1.23

0.23

1.2

2.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

264

0.87

0.23

1.3

1.4

g/l

6.0

6.9

0.71

188

(3024139) IgG subclass 3 [Mass/volume] in Serum

264

0.87

0.23

1.3

1.4

g/l

0.3

0.4

1.76

188

(3028192) IgG subclass 2 [Mass/volume] in Serum

264

0.87

0.23

1.3

1.4

g/l

2.3

3.0

2.24

187

(3009214) Lutropin [Units/volume] in Serum or Plasma

452

0.91

0.22

1.4

1.3

u/l

21.6

9.0

2.86

367

(3015183) Erythrocyte sedimentation rate

0.74

0.22

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

189

0.85

0.22

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

419

1.10

0.22

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

101

0.79

0.21

1.1

1.2

—

0.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

239

2474

0.96

0.21

3.1

3.8

ng/l

93.0

97.3

0.27

200

2074

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.22

0.21

1.2

1.6

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.20

0.0

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

0.84

0.20

1.1

—

(3006270) Folate [Moles/volume] in Blood

313

0.89

0.20

1.3

1.2

nmol/l

362.4

341.7

0.20

250

(3008295) Osmolality of Serum or Plasma

288

1.11

0.19

1.3

1.4

mosm/kgh2o

274.5

278.5

0.52

214

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.20

0.19

1.0

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

118

1.19

0.19

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

118

1.19

0.19

1.1

2.0

66.0

72.1

1.05

108

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

653

0.93

0.19

1.3

1.5

nmol/l

1.0

0.8

1.29

528

(4027681)

132

0.83

0.18

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

185

1784

1.04

0.18

5.9

3.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.17

0.17

1.0

2.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.15

0.17

1.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.11

0.17

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.72

0.16

1.2

pmol/l

163.8

236.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

755

7439

1.02

0.16

1.7

pmol/l

13849097.6

30583587.0

0.56

621

6036

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.77

0.15

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

328

0.91

0.15

1.1

1.2

mmol/l

7.7

7.8

0.00

227

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.75

0.15

1.0

1.1

—

(4306422)

361

1.08

0.15

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

1.14

0.15

1.1

—

(3047189) Immunofixation for 24 hour Urine

131

1.15

0.14

1.7

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

118

0.85

0.14

1.0

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.82

0.13

2.9

3.0

mu/l

14.4

20.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.81

0.13

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

0.83

0.13

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

229

1.09

0.12

1.1

1.2

—

5.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

610

0.95

0.12

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

649

1.05

0.12

1.6

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

493

1.06

0.11

1.4

—

(3016750) Collection duration of Urine

209

0.91

0.11

1.8

2.0

min

493.1

496.7

0.05

154

(4268621)

240

1.08

0.11

2.3

2.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

0.88

0.11

1.1

—

(3017704) Immunofixation for Urine

192

1.09

0.10

1.3

1.2

—

(40761535) Cells panel - Urine sediment

292

2868

1.02

0.10

3.0

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

153

1491

1.03

0.10

1.9

1.4

g/l

1.4

1.1

0.62

141

1343

(40768443) Skin Pathology biopsy report

118

1214

0.97

0.10

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.11

0.09

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.82

0.08

1.4

1.5

ng/l

91.2

140.4

—

(3006462) Nitrate [Presence] in Urine

146

1.10

0.08

4.7

3.4

—

(3016228) CD19 cells/100 cells in Blood

1.08

0.08

1.0

2.2

10.1

7.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.04

0.08

1.1

umol/l

18.6

15.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

352

1.05

0.07

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.86

0.07

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.83

0.07

1.3

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

388

0.95

0.07

1.1

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1467

14732

0.99

0.07

2.2

2.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.07

0.07

1.0

2.1

—

135406.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.04

0.07

2.4

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.87

0.07

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

412

1.04

0.07

1.7

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.82

0.07

1.7

1.8

ug/l

0.9

1.1

—

(3028433) Virus identified in Specimen by Culture

1.03

0.07

1.3

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.89

0.06

4.6

7.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.86

0.06

1.0

1.3

—

(3010503) CD19 cells [#/volume] in Blood

104

0.86

0.06

1.0

1.9

e9/l

0.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

416

0.96

0.06

1.3

1.7

g/l

1.2

0.9

0.28

318

(3026389) Candida sp identified in Specimen by Organism specific culture

345

1.04

0.06

1.0

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

831

1.02

0.05

3.0

3.1

nmol/l

0.8

0.53

644

(3006653) Thiamine [Moles/volume] in Blood

151

0.93

0.05

1.0

1.2

nmol/l

154.6

140.2

0.26

151

(4024509)

343

0.96

0.05

1.7

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

150

1.07

0.04

1.1

1.3

mmol/l

6.0

6.2

0.47

139

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

348

1.03

0.04

1.2

1.3

nmol/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

350

3523

0.99

0.04

2.0

2.4

ug/l

6.1

7.5

0.94

297

3075

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

139

0.93

0.03

1.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

371

0.97

0.03

1.2

1.3

pmol/l

212.6

277.4

1.22

279

(3020630) Protein [Mass/volume] in Serum or Plasma

279

2769

1.01

0.03

2.6

1.6

g/l

64.4

66.7

4.46

250

2453

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1220

12166

1.00

0.03

2.1

2.2

nmol/l

76.1

78.7

2.23

1061

10564

(21494890) Protein electrophoresis panel - 24 hour Urine

320

1.03

0.03

2.6

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

249

2506

0.99

0.03

1.4

—

(3003338) MCHC [Mass/volume]

2437

24337

1.00

0.02

41.2

18.7

g/l

330.0

332.4

31.78

2415

24092

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

361

1.02

0.02

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

969

0.99

0.01

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

808

0.99

0.01

1.4

1.5

g/l

1.1

1.2

0.62

765

(3038026) Centromere Ab [Units/volume] in Serum

251

1.00

0.00

1.1

1.2

—

65.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

203

0.98

0.00

1.2

1.5

umol/l

15.6

14.2

0.33

187

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

145

1.03

0.00

1.0

1.5

—

(44806420)

136

1.03

0.00

2.4

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

349

1.00

0.00

3.2

3.1

mg/l

43.6

38.8

0.11

269

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

329

1.00

0.00

3.1

3.7

—

(3011985) Renin [Units/volume] in Plasma

395

0.99

0.00

1.3

mu/l

46.1

63.3

0.60

351

(3027923) C peptide [Moles/volume] in Serum or Plasma

185

1.03

0.00

1.4

1.3

nmol/l

1.1

1.2

0.15

141

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

0.96

0.00

5.1

7.8

—

(40768446) Kidney Pathology biopsy report

112

0.98

0.00

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

170

1.00

0.00

3.1

4.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

356

1.01

0.00

1.2

u/ml

197.4

282.9

1.96

222

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

4.2

—

23.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(4198724)

0.98

0.00

1.8

1.6

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.4

—

633.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.94

0.00

1.0

1.1

128.3

99.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.9

—

(4038314)

0.00

0.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1215.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.94

0.00

1.2

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

283.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.98

0.00

4.9

1.7

221.3

160.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.90

0.00

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

0.95

0.00

1.3

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

3.8

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_ADENO_MUCINO_EXALLC – Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

GWS hits: 11

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers) (C3_RECTUM_ADENO_MUCINO_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints